Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $5.50 million. The enterprise value is -$1.31 million.
Important Dates
The next estimated earnings date is Tuesday, April 15, 2025, before market open.
| Earnings Date | Apr 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 4.27 million shares outstanding. The number of shares has increased by 1,431.07% in one year.
| Current Share Class | 4.27M |
| Shares Outstanding | 4.27M |
| Shares Change (YoY) | +1,431.07% |
| Shares Change (QoQ) | +14.62% |
| Owned by Insiders (%) | 3.01% |
| Owned by Institutions (%) | 9.45% |
| Float | 3.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.72 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -158.87 |
Financial Efficiency
Return on equity (ROE) is -256.89% and return on invested capital (ROIC) is -173.28%.
| Return on Equity (ROE) | -256.89% |
| Return on Assets (ROA) | -54.37% |
| Return on Invested Capital (ROIC) | -173.28% |
| Return on Capital Employed (ROCE) | -183.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $377,966 in taxes.
| Income Tax | 377,966 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.23% in the last 52 weeks. The beta is -1.48, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.48 |
| 52-Week Price Change | -16.23% |
| 50-Day Moving Average | 1.41 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 40.62 |
| Average Volume (20 Days) | 91,052 |
Short Selling Information
The latest short interest is 326,807, so 7.66% of the outstanding shares have been sold short.
| Short Interest | 326,807 |
| Short Previous Month | 410,380 |
| Short % of Shares Out | 7.66% |
| Short % of Float | 8.61% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.74M |
| Pretax Income | -6.68M |
| Net Income | -5.25M |
| EBITDA | -5.73M |
| EBIT | -5.74M |
| Earnings Per Share (EPS) | -$1.69 |
Full Income StatementBalance Sheet
The company has $6.86 million in cash and $53,142 in debt, giving a net cash position of $6.81 million or $1.60 per share.
| Cash & Cash Equivalents | 6.86M |
| Total Debt | 53,142 |
| Net Cash | 6.81M |
| Net Cash Per Share | $1.60 |
| Equity (Book Value) | 3.11M |
| Book Value Per Share | 0.73 |
| Working Capital | 2.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.86M |
| FCF Per Share | -$1.14 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |